Hims & Hers offers a copycat of the blockbuster weight-loss drug at a fraction of the cost. But it might be a short-lived ...

Clinical trials have found that people who are on the prescription for a year can lose more than 10% of their body weight.

A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.

Novo CEO Lars Fruergaard Jorgensen sees Wegovy supply improving this year, and brushed off fears of the company falling behind Eli Lilly & Co. Details about its next-generation weight loss drugs ...

Sales of weight loss drug Wegovy more than doubled in the final ... or by people sending in photos of themselves.

Novo's earnings results Wednesday differ from Eli Lilly's, whose stock slid on slower-than-expected sales of weight loss ...